ABSTRACT Eight patients, five with chronic granulocytic leukaemia and three with severe aplastic anaemia, developed moderately severe airflow obstruction after allogeneic bone marrow transplantation. All eight had clinically and radiologically normal lungs before undergoing transplantation. Treatment in the patients with chronic granulocytic leukaemia before transplantation included high dose total body irradiation. All eight patients developed acute and chronic graft versus host disease after transplantation. The pulmonary syndrome consisted of cough, dyspnoea, and wheezing beginning six to 20 weeks after transplantation, with ratios of forced expiratory volume in one second (FEV1) to vital capacity (VC) falling to 60% or less of predicted values. The three patients with severe aplastic anaemia had relatively mild graft versus host disease and acute chest infection may have initiated or contributed to their airways obstruction, which subsequently resolved. The five patients with chronic granulocytic leukaemia had more severe graft versus host disease and more progressive respiratory problems; two died and three continued to have persistent airflow obstruction 11, 15, and 20 months after transplantation. None of those with chronic granulocytic leukaemia improved. Transfer factor (TLco) was reduced in all patients after bone marrow transfer and did not improve; in the patients with chronic granulocytic leukaemia the reduction in TLCO preceded the fall in FEV1/VC ratio. Open lung biopsy in one of the patients with chronic granulocytic leukaemia showed obliterative bronchiolitis with lymphocytic infiltration consistent with graft versus host disease. Bronchodilators were of no benefit in the management of these patients, but prompt treatment of infection and early use of corticosteroids may have contributed to the improvement seen in the patients with severe aplastic anaemia.
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Discussion
INCIDENCE OF THE PULMONARY SYNDROME The incidence of this pulmonary syndrome (table 3) in our practice was at least 13% (eight out of 64 patients surviving three or more months after bone marrow transplantation). It may have been more common after bone marrow transplantation for chronic granulocytic leukaemia than for severe aplastic anaemia (18% v 8% respectively), but the numbers were too small to draw firm conclusions.
The TLco was reduced after transplantation in all the patients (fig 2) but the airflow obstruction differed in timing and outcome in the two groups; the patients with chronic granulocytic leukaemia presented with a low TLCO without much obstruction Table 3 Relation ofseverity ofgraft versus host disease (GVHD) to incidence ofairways obstruction in 28 patients transplanted for chronic granulocytic leukaemia (CGL) and 36 patients transplanted for severe aplastic anaemia (SAA) who survived at least three months after bone marrow transplantation (BMT) (table 1) , and, though this may have been an aggravating factor, their clinical course and functional changes resembled those of the non-smokers. The clinical picture in these patients was similar to that referred to as obliterative bronchiolitis. Obliterative bronchiolitis is characterised by rapidly progressive severe airways obstruction in the absence of chronic bronchitis.'5 It has been described after viral infections in children,'6 after exposure to nitrogen dioxide in adults,'7 and in association with connective tissue disorders,'8 including rheumatoid arthritis'9 and Sjogren's syndrome. 20 Generalised necrotising obliterative bronchiolitis has also been reported in one patient with graft versus host disease.9 The viral and toxic forms are generally associated with an acute illness after exposure to the initiating agent, followed one to three weeks later by the onset of progressive breathlessness with nodular shadows or an appearance similar to pulmonary oedema on the chest radiograph. The response to corticosteroids was usually reasonably good.
The clinical picture in the patients with chronic granulocytic leukaemia fitted quite well with this condition. This 
